Don't blame the stents

Journal of the American College of Cardiology

Volumn 43, Issue 8, 2004, Pages 1355-1357

  Vetrovec, George W ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; CLOPIDOGREL; FIBRINOGEN RECEPTOR ANTAGONIST; FLUINDOSTATIN; INSULIN; ORAL ANTIDIABETIC AGENT; STATIN;

CLINICAL TRIAL; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CORONARY STENT; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HUMAN; NOTE; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STROKE;

EID: 1942452461     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2004.01.018     Document Type: Editorial

References (18)

1. Mathew V., Holmes D.R. Outcomes in diabetics undergoing revascularization The long and the short of it. J Am Coll Cardiol. 40:2002;424-427.
2. Srinivas VS, Brooks MM, Detre KM, et al. Contemporary percutaneous coronary intervention versus balloon angioplasty for multivessel coronary artery disease: a comparison of the National Heart, Lung and Blood Institute Dynamic Registry and the Bypass Angioplasty Revascularization Investigation (BARI) study. Circulation 2002;1061627-33.
3. Van Belle E., Perie M., Braune D., et al. Effects of coronary stenting on vessel patency and long-term clinical outcome after percutaneous coronary revascularization in diabetic patients. J Am Coll Cardiol. 40:2002;410-417.
4. The Bypass Angioplasty Revascularization Investigation (BARI) Investigators. Comparison of coronary bypass surgery with angioplasty in patients with multivessel disease. N Engl J Med. 335:1996;217-225.
5. The BARI Investigators. Influence of diabetes on 5-year mortality and morbidity in a randomized trial comparing CABG and PTCA in patients with multivessel disease. Circulation. 96:1997;1761-1769.
6. King S.B., Kosinski A.S., Guyton R.A., et al. Eight-year mortality in the Emory Angioplasty versus Surgery Trial (EAST). J Am Coll Cardiol. 35:2000;1116-1121.
7. Serruys P.W., Unger F., Sousa J.E., et al. Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med. 344:2001;1117-1124.
8. Abizaid A., Costa M.A., Centemero M., et al. Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients Insights from the Arterial Revascularization Therapy Study (ARTS) trial. Circulation. 104:2001;533-538.
9. CABRI investigators, Kurbaan A.S., Bowker T.J., Ilsley C.D., et al. Difference in the mortality of the CABRI diabetic and nondiabetic populations and its relation to coronary artery disease and the revascularization mode. Am J Cardiol. 87:2001;947-950.
10. Van den Brand M.J., Rensing B.J., Morel M.A., et al. The effect of completeness of revascularization on event-free survival at one year in the ARTS Trial. J Am Coll Cardiol. 39:2002;559-564.
11. Mehran R, Dangas GD, Kobayashi Y, et al. Short- and long-term results after multivessel stenting in diabetic patients. J Am Coll Cardiol 2004;43:1348-54.
12. Detre K.M., Guo P., Holubkov R., et al. Coronary revascularization in diabetic patients A comparison of the randomized and observational components of the Bypass Angioplasty Revascularization Investigation (BARI). Circulation. 99:1999;633-640.
13. King S.B., Barnhart H.X., Kosinski A.S., et al. Angioplasty or surgery for multivessel coronary artery disease Comparison of eligible registry and randomized patients in the EAST trial and influence of treatment selection on outcomes. Emory Angioplasty versus Surgery Trial Investigators. Am J Cardiol. 79:1997;1453-1459.
14. Bhatt D.L., Marso S.P., Lincoff A.M., et al. Abciximab reduces mortality in diabetics following percutaneous coronary intervention. J Am Coll Cardiol. 35:2000;922-928.
15. Surruys P.W., deFeyter P., Macaya C., Kokott N., et al. Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention A randomized controlled trial. JAMA. 287:2002;3215-3222.
16. Schwartz G.G., Olsson A.G., Ezekowitz M.D., et al. Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes The MIRACL study: a randomized controlled trial. JAMA. 285:2001;1711-1718.
17. Steinhubl S.R., Berger P.B., Mann J.T., et al. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention A randomized controlled trial. JAMA. 288:2002;2411-2420.
18. SIRIUS investigators, Moses J.W., Leon M.B., Popma J.J., et al. Sirolimus-Eluting Stents versus Standard Stents in Patients with Stenosis in a Native Coronary Artery. N Engl J Med. 349:2003;1315-1323.